Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Folkers

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
NIAID AIDS Agenda|April 1, 1995
NIAID studies of interleukin-2. National Institute of Allergy and Infectious DiseasesG Folkers
Archiv Der Pharmazie|September 1, 1985
[The formation of potential toxic by-products in the in vitro decomposition of alpha-aminoalcohols]G Folkers
NIAID AIDS Agenda|December 1, 1995
ACTG 175: new insights into treating patients with intermediate-stage HIV diseaseG Folkers
NIAID AIDS Agenda|June 1, 1996
Immune system activation boosts HIV replication in HIV-infected peopleG Folkers
NIAID AIDS Agenda|June 1, 1996
Antiretrovirals plus immunomodulators: didanosine/interferon-alpha combination shows promiseG Folkers
NIAID AIDS Agenda|August 1, 1997
CD4+ T cell diversity not immediately restored by therapyG Folkers
Public Health Reports (Washington, D.C. : 1974)|July 1, 1993
NIAID mounts nationwide HIV-TB treatment studyG Folkers
NIAID AIDS Agenda|December 1, 1995
NIAID funds adult AIDS clinical trials group. National Institute of Allergy and Infectious DiseasesG Folkers
NIAID AIDS Agenda|March 1, 1996
Putative KS virus grown in laboratoryG Folkers
NIAID AIDS Agenda|March 1, 1996
Two new protease inhibitors approved by FDA. Food and Drug AdministrationG Folkers
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
NIAID AIDS Agenda|April 1, 1995
NIAID studies of interleukin-2. National Institute of Allergy and Infectious DiseasesG Folkers
Archiv Der Pharmazie|September 1, 1985
[The formation of potential toxic by-products in the in vitro decomposition of alpha-aminoalcohols]G Folkers
NIAID AIDS Agenda|December 1, 1995
ACTG 175: new insights into treating patients with intermediate-stage HIV diseaseG Folkers
NIAID AIDS Agenda|June 1, 1996
Immune system activation boosts HIV replication in HIV-infected peopleG Folkers
NIAID AIDS Agenda|June 1, 1996
Antiretrovirals plus immunomodulators: didanosine/interferon-alpha combination shows promiseG Folkers
NIAID AIDS Agenda|August 1, 1997
CD4+ T cell diversity not immediately restored by therapyG Folkers
Public Health Reports (Washington, D.C. : 1974)|July 1, 1993
NIAID mounts nationwide HIV-TB treatment studyG Folkers
NIAID AIDS Agenda|December 1, 1995
NIAID funds adult AIDS clinical trials group. National Institute of Allergy and Infectious DiseasesG Folkers
NIAID AIDS Agenda|March 1, 1996
Putative KS virus grown in laboratoryG Folkers
NIAID AIDS Agenda|March 1, 1996
Two new protease inhibitors approved by FDA. Food and Drug AdministrationG Folkers
Pageof 12